1. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7 (2):132-140. doi:10.1007/s11894-005-0051-8
2. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172-187. doi:10.5009/gnl. 2012.6.2.172
3. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-639. doi:10.1016/s0016-5085(99)70456-7
4. Karayalcin R, Genc V, Karaca AS, Ozaksit G. Prevalence of cholelithiasis in a Turkish population sample of postmenopausal women. Turk J Gastroenterol. 2010;21(4):416-420.
5. Trotman BW, Soloway RD. Pigment gallstone disease: summary of the National Institutes of Health--international workshop. Hepatology. 1982;2(6):879-884. doi:10.1002/hep.1840020624
6. Vitek L, Carey MC. Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life. Eur J Clin Invest. 2003;33(9):799-810. doi:10.1046/j.1365-2362.2003.01214.x
7. Aydogdu I, Sari R, Ulu R, Sevinc A. The frequency of gallbladder stones in patients with pernicious anemia. J Surg Res. 2001;101(2):120-123. doi: 10.1006/jsre.2001.6269
8. Pamuk GE, Umit H, Harmandar F, Yesil N. Patients with iron deficiency anemia have an increased prevalence of gallstones. Ann Hematol. 2009; 88(1):17-20. doi: 10.1007/s00277-008-0557-x
9. Cikim G, Hatipoglu HS, Susam S. Evaluation of homocysteine, vitamin, and trace element levels in women with gallstones. J Trace Elem Med Biol. 2023;78:127177. doi:10.1016/j.jtemb.2023.127177
10. Chen P, Yang C, Ding J, Li Y, Hu W, Zhang Q. Association of dietary vitamin intake with gallstone risk in US adults: a cross-sectional NHANES study. Eur J Med Res. 2025;30(1):535. doi:10.1186/s40001-025-02841-8
11. Liu CM, Hsu CT, Li CY, Chen CC, Liu ML, Liu JH. A population-based cohort study of symptomatic gallstone disease in diabetic patients. World J Gastroenterol. 2012;18(14):1652-1659. doi:10.3748/wjg.v18.i14.1652
12. Liu CM, Tung TH, Chou P, et al. Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. World J Gastroenterol. 2006;12(8):1281-1286. doi:10.3748/wjg.v12.i8.1281
13. Loria P, Lonardo A, Lombardini S, et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol. 2005;20(8):1176-1184. doi:10.1111/j.1440-1746.2005.03924.x
14. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11(11):1653-1657. doi:10.3748/wjg.v11.i11.1653
15. Zhuo H, Fan J, Zhang B, et al. Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure. Open Med (Wars). 2022;17(1):1455-1465. doi:10.1515/med-2022-0549
16. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107(5):1747-1750. doi:10.1182/blood-2005-07-3046
17. Adeniyi OF, Akinsete AM, Odeghe EA, et al. Cholelithiasis in children and adolescents with sickle cell disease: experience in a resource-limited setting. Ann Afr Med. 2022;21(1):58-64. doi:10.4103/aam.aam_81_20
18. Aguado A, Moratalla-Navarro F, Lopez-Simarro F, Moreno V. MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity. Sci Rep. 2020;10(1):2416. doi:10.1038/s41598-020-59336-1
19. Alkindi S, Almufargi SS, Pathare A. Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients. Exp Biol Med (Maywood). 2020;245(1):79-83. doi:10.1177/15353 70219892846
20. Al Talhi Y, Shirah BH, Altowairqi M, Yousef Y. Laparoscopic cholecystectomy for cholelithiasis in children with sickle cell disease. Clin J Gastroenterol. 2017;10(4):320-326. doi:10.1007/s12328-017-0750-3
21. Cuciureanu T, Singeap AM, Chiriac S, Girleanu I, Trifan A, Stanciu C. An unusual case of cholecystoduodenal fistula in a nonagenarian patient. Medical-Surgical Journal-Revista Medico-Chirurgicala. 2017; 121(2):360-365.
22. Mohammed S, Addae S, Suleiman S, et al. Serum calcium, parathyroid hormone, and vitamin D status in children and young adults with sickle cell disease. Ann Clin Biochem. 1993;30(1):45-51. doi:10.1177/0004563293 03000108
23. Ariandi I, Saleh S, Benyamin AF, Harjianti T, Minhajat R, Bayu D. ß-thalassemia intermedia with autoimmune hemolytic anemia and multiple cholelithiasis complications. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2023;182(4):240-243. doi:10.23736/s03 93-3660.22.04881-1
24. Gardner K, Suddle A, Kane P, et al. How we treat sickle hepatopathy and liver transplantation in adults. Blood. 2014;123(15):2302-2307. doi:10. 1182/blood-2013-12-542076
25. AlSaleh N, Alaa Adeen AM, Hetta OE, et al. Emergency cholecystectomy: risk factors and impact of delay on electively booked patients, a 5-year experience of a tertiary care center. BMC Surg. 2024;24(1):396. doi:10.1186/s12893-024-02694-8
26. Rege RV. Biliary stones. Current Opinion in Gastroenterology. 1992;8(5): 749-755. doi:10.1097/00001574-199210000-00004
27. Rosenbaum H, Sidransky E. Cholelithiasis in patients with Gaucher disease. Blood Cells Mol Dis. 2002;28(1):21-27. doi:10.1006/bcmd.2001.0480
28. Lotfi M, Keramati P, Assdsangabi R, Nabavizadeh SA, Karimi M. Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran. Med Sci Monit. 2009;15(8):CR398-402.
29. Siregar DR, Muhar AM, Pohan DP. The role of cholelithiasis risk factors in stone types in cholelithiasis patients at Universitas Sumatera Utara Hospital. Bali Medical Journal. 2021;10(1):63-65. doi:10.15562/bmj.v10 i1.2139